Latest News about Health Canada Approval
Recent news which mentions Health Canada Approval
From Benzinga
Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
May 11, 2023
Tickers
OPTHF
From Benzinga
From Benzinga
This Psychedelic-Assisted Therapy Study Offers Therapists Experience With Magic Mushroom Tea
February 01, 2023
Tickers
NUMIF
From Benzinga
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
January 24, 2023
From Benzinga
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
January 21, 2023
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
From Benzinga
Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial
November 30, 2022
From Benzinga
New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details
September 17, 2022
Tickers
NMLSF
From Benzinga
Merck Secures Canadian Regulatory Nod For KEYTRUDA In Skin Cancer After Resection
September 13, 2022
Tickers
MRK
From Benzinga
Bristol Myers Squibb Secures Canadian Regulatory Nod For Lung Cancer Candidate In Neoadjuvant Setting
August 23, 2022
Tickers
BMY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.